© 1993 British Society for Rheumatology
other |
DIFFERENTIATING PERSISTENT FROM SELF-LIMITING SYMMETRICAL SYNOVITIS IN AN EARLY ARTHRITIS CLINIC
Department of Rheumatology, University of Birmingham Birmingham B15 2TJ
Correspondence to:
Correspondence to Dr E. Tunn, Rheumatic Diseases Unit, Royal Liverpool University Hospital, Liverpool L7 8XP
Early rheumatoid arthritis (RA) must be differentiated from benign self-limiting polyarthritis because of the risks associated with treatment of RA. Conventional, widely available clinical and laboratory variables, measured at first clinic visit, were studied for their ability to predict persistance in 112 patients with up to 6 months ofjoint symptoms. Those 65 patients with symmetrical peripheral polyarthritis were followed for 1 year: 36 who underwent spontaneous remission were classified self-limiting synovitis (SLS); the remaining 29 were termed persistent synovitis (PS). Univariate analysis suggested more severe disease in PS at presentation but showing considerable overlap with SLS, making clinical discrimination difficult. Multivariate analysis confirmed this overlap but identified a subset of most helpful variables. The RA latex was the most powerful variable, yet accounted for only 45% of the variability in outcome. Combining a positive RA latex with an ESR>30 mm/h carried a relative risk for PS of 4.33, with specificity 94% but sensitivity only 69%. Self-limiting synovitis initially could not be distinguished from early RA: hence RA may exist in two forms, the traditional persistent form and a less well recognized abortive form.
KEY WORDS: Early rheumatoid arthritis, Acute polyarthritis, Persistent synovitis, Multivariate analysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. P. M. Symmons Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor? Rheumatology, May 1, 2007; 46(5): 725 - 726. [Full Text] [PDF] |
||||
![]() |
K. P. Machold, T. A. Stamm, V. P. K. Nell, S. Pflugbeil, D. Aletaha, G. Steiner, M. Uffmann, and J. S. Smolen Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease Rheumatology, February 1, 2007; 46(2): 342 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Suresh and C M Lambert Combination treatment strategies in early rheumatoid arthritis Ann Rheum Dis, September 1, 2005; 64(9): 1252 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Suresh Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know J R Soc Med, September 1, 2004; 97(9): 421 - 424. [Full Text] [PDF] |
||||
![]() |
J S Smolen and D Aletaha Patients with rheumatoid arthritis in clinical care Ann Rheum Dis, March 1, 2004; 63(3): 221 - 225. [Full Text] [PDF] |
||||
![]() |
L M A Jansen, D van Schaardenburg, I E van der Horst-Bruinsma, and B A C Dijkmans One year outcome of undifferentiated polyarthritis Ann Rheum Dis, August 1, 2002; 61(8): 700 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Emery, F C Breedveld, M Dougados, J R Kalden, M H Schiff, and J S Smolen Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide Ann Rheum Dis, April 1, 2002; 61(4): 290 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Quinn, P. G. Conaghan, and P. Emery The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology, November 1, 2001; 40(11): 1211 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
F M McQueen, N Benton, J Crabbe, E Robinson, S Yeoman, L McLean, and N Stewart What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease Ann Rheum Dis, September 1, 2001; 60(9): 859 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Harrison and D. Symmons Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years Rheumatology, September 1, 2000; 39(9): 939 - 949. [Full Text] [PDF] |
||||
![]() |
B. J. Harrison, A. J. Silman, D. P. M. Symmons, C. T. Pease, B. Bhakta, J. Devlin, and P. Emery Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors Rheumatology, January 1, 2000; 39(1): 112 - 113. [Full Text] [PDF] |
||||
![]() |
J L Hülsemann and H Zeidler Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic Ann Rheum Dis, May 1, 1999; 58(5): 278 - 280. [Abstract] [Full Text] |
||||
![]() |
R. Munro, R. Hampson, A. McEntegart, E A. Thomson, R. Madhok, and H. Capell Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study Ann Rheum Dis, February 1, 1998; 57(2): 88 - 93. [Abstract] [Full Text] |
||||
![]() |
J. M. Cash and J. H. Klippel Second-Line Drug Therapy for Rheumatoid Arthritis N. Engl. J. Med., May 12, 1994; 330(19): 1368 - 1375. [Full Text] |
||||



